Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 17, 2004

View Archived Issues

Synthetic flavonol reduces infarct size and myocardial injury in sheep

Prostaglandin E2 receptor agonist accelerates bone repair in rats

Chloride channel inhibitor prevents bone resorption in ovariectomized rats

Protective effects of vardenafil in the ischemic heart

Enrollment begins in phase II trial of MC-4232

Vicuron reports phase III results for dalbavancin in SSTIs

Sanctura distribution under way

BLA submission for Adacel vaccine

Adderall XR receives FDA approval for use in adults

A.P. Pharma reports initial data for APF-112 and APF-530

Dexanabinol receives orphan drug status

AV-201 cleared to enter phase I/II trial for Parkinson's disease

Spectrum acquires North American, Indian rights to D-631153

Enhance Biotech and Ardent Pharmaceuticals in definitive merger agreement

Topamax approved for migraine prophylaxis

New bradykinin antagonists emerges from Elan R&D

Mexican launch for Sucanon planned

Wyeth and Cambridge Antibody Technology claim new anti-PD-1 antibodies

Guilford plans major PCI trials for Aggrastat

Takeda scientists prepare and evaluate anti-urotensin II antibodies

NeuroSearch and TopoTarget collaborate on Endovion development

New monoamine reuptake inhibitors and their use in pain, emesis and other disorders

BMS researchers design novel serotonin receptor modulators for use as antiobesity agents

Novel factor Xa inhibitors in early development at Boehringer Ingelheim

New PPAR modulators prepared and evaluated by AstraZeneca team

Melanocortin receptor antagonist promising for treatment of obesity and affective disorders

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...